CYBX Related Analyst Ratings
-
Lazard Capital Upgrades Cyberonics (CYBX) to Buy
-
Amid Sell-Off, Sidoti Upgrades Cyberonics (CYBX) to Buy
-
Cyberonics (CYBX) Slammed as Whistleblower, Valuation Bubble Revealed
-
Northland Securities Upgrades Cyberonics (CYBX) to Underperform
-
Jefferies Maintains a 'Buy' on Cyberonics (CYBX); First Depression Paper Released
-
UPDATE: Canaccord Genuity Upgrades Cyberonics (CYBX) to Buy; Overcoming Pessimistic Expectations
-
Jefferies Reiterates a 'Buy' on Cyberonics (CYBX); Remains Top Small-Cap Pick After Strong Q1
-
William Blair Starts Cyberonics (CYBX) at Outperform
-
Jefferies Reiterates a 'Buy' on Cyberonics (CYBX); Depression Would Effectively Double the Addressable Market for VNS
-
Cyberonics (CYBX) Shares Lower as Sidoti Downgrades to Neutral
-
Cyberonics (CYBX) Shares Rally as Craig-Hallum Starts at Buy, $48 Price Target
-
Lazard Capital Downgrades Cyberonics (CYBX) to Neutral
-
Jefferies Raises Numbers On Cyberonics (CYBX) After "Excellent" Q3
-
Canaccord Genuity Maintains a 'Hold' on Cyberonics (CYBX); Q3 Strong on U.S. ASPs; OUS Initiative Shows Potential
-
Kaufman Bros. on Medical Technology - Keeping Things Simple as We Enter 2012
-
Kaufman Bros. Upgrades Cyberonics (CYBX) to Buy; Things Are Balancing Out
-
Northcoast Research Starts Cyberonics (CYBX) at Buy, $35.50 Price Target
-
Kaufman Bros. Starts Cyberonics (CYBX) at Hold, Sets Price Target at $28
-
Jefferies Lowers Price Target on Cyberonics (CYBX), Solid Q1 Results Despite Market Trends
-
WBB Securities Upgrades Cyberonics (CYBX) to Strong Buy
-
Canaccord Genuity Maintains a 'Hold' on Cyberonics (CYBX); Weak OUS Sales Impact Qtr and Guidance; US Strength Continues
-
SunTrust Robinson Humphrey Upgrades Cyberonics (CYBX) to Neutral
-
Jefferies Starts Cyberonics (CYBX) at Buy
-
SunTrust Robinson Humphrey Downgrades Cyberonics (CYBX) to Reduce
-
Canaccord Genuity Maintains a 'Hold' on Cyberonics (CYBX); Strong FQ4/10
-
Piper Jaffray Reiterates an 'Overweight' Rating on Cyberonics (CYBX); Updates Model for FQ4-10
-
Canaccord Adams Maintains a 'Hold' on Cyberonics (CYBX); FQ4/10 Preview: Expect Positive News on Japanese Reimbursement
-
Maxim Group Assumes Coverage on Cyberonics (CYBX) with a Hold
-
WBB Securities Downgrades Cyberonics (CYBX) to Buy
-
Piper Jaffray Positive On Med Tech Stocks In '10
-
Baird Upgrades Cyberonics (CYBX) to Outperform
-
Ameriprise Financial Initiates Coverage on Cyberonics (CYBX) with a Buy
-
Baird Initiates Coverage on Cyberonics (CYBX) with a Neutral
-
Piper Jaffray Upgrades Cyberonics, Inc. (CYBX) to Overweight
-
Sidoti Starts Cyberonics (CYBX) at Buy But Stock Selling-Off
-
WBB Securities Upgrades Cyberonics (CYBX) to Strong Buy
-
Matrix Lighthouse Rating Changes 2/23
-
Cyberonics (CYBX) Jumps on Lazard Upgrade
-
Piper Jaffray Upgrades Cyberonics (CYBX) to Buy
-
Collins Stewart Downgrades Cyberonics (CYBX) to Hold On Valuation
-
Canaccord Adams Boosts Price Target On Cyberonics (CYBX) to $28.75, Following Better Results
-
Collins Stewart upgrades Cyberonics (CYBX) to Buy
-
Lazard Capital Upgrades Cyberonics (CYBX) to Hold
-
Lazard Says Sell Cyberonics Inc. (CYBX) Ahead of Friday's FDA Advisory Panel Meeting
-
Piper Jaffray downgrades Cyberonics (CYBX) to Market Perform
-
Cyberonics (CYBX) Option Implied Volatility at 54, CYBX confirms SEC option grant Probe
-
SunTrust downgrades Cyberonics (CYBX) to Neutral
-
Lazard Capital Upgrades Cyberonics (CYBX) to Hold
-
C.E Unterberg Towbin downgrades Cyberonics (CYBX) to Market Perform
-
Cyberonics (CYBX) Up In Early Trading, Piper Jaffray Analyst Comments
Back to CYBX Stock Lookup
